Fresenius Medical Care AG ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $23B+15.1% YoYTTM through 31 Dec 2025
Net Income $1.1B+106.2% YoYTTM through 31 Dec 2025
Free Cash Flow $1.8BTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| EBITDA Margin | 16.8% |
| Operating Margin | 9.3% |
| Net Margin | 5.0% |
Returns
6.9%ROE
3.2%ROA
5.5%ROIC
Balance Sheet Health
Debt / Equity0.76x
Current Ratio1.26x
Net Debt$9.2B
Cash & Equivalents$1.6B
Quality Metrics
Altman Z-Score1.72
Piotroski F-Score6 / 9
FCF Margin7.7%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $19.6B
Diluted EPS$3.36TTMFY2025: $3.36
Dividend
$0.87Per share, FY20263.88%Yield3 yrsStreak+0.9%5-yr growth
Capital Allocation
R&D Spend$158M
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Care Delivery | |||
| Value-Based Care | +42.0% |
Financials converted at 0.8513 from EUR.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.